➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Medtronic
Dow

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: LAMIVUDINE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

LAMIVUDINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Viiv Hlthcare EPIVIR lamivudine SOLUTION;ORAL 020596 NDA ViiV Healthcare Company 49702-205-48 240 mL in 1 BOTTLE (49702-205-48)
Glaxosmithkline EPIVIR-HBV lamivudine SOLUTION;ORAL 021004 NDA GlaxoSmithKline LLC 0173-0663-00 240 mL in 1 BOTTLE (0173-0663-00)
Aurobindo Pharma Ltd LAMIVUDINE lamivudine SOLUTION;ORAL 077695 ANDA Rising Health, LLC 57237-274-24 240 mL in 1 BOTTLE (57237-274-24)
Aurobindo Pharma Ltd LAMIVUDINE lamivudine SOLUTION;ORAL 077695 ANDA Aurobindo Pharma Limited 65862-055-24 240 mL in 1 BOTTLE (65862-055-24)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Boehringer Ingelheim
Moodys
Medtronic
McKinsey